Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Jinlida granules combined with metformin improved the standard-reaching rate of blood glucose and clinical symptoms of patients with type 2 diabetes: secondary analysis of a randomized controlled trial.
Kang X, Sun Y, Duan Y, Zhang Y, An X, Jin D, Lian F, Tong X. Kang X, et al. Among authors: jin d. Front Endocrinol (Lausanne). 2023 May 25;14:1142327. doi: 10.3389/fendo.2023.1142327. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37305056 Free PMC article. Clinical Trial.
The Clinical Efficacy of Gegen Qinlian Decoction in Treating Type 2 Diabetes is Positively Correlated with the Dose of Coptidis rhizoma: Three Randomized, Doubleblind, Dose-Parallel Controlled Clinical Trials.
Kang X, Jin D, Ji H, An X, Zhang Y, Duan L, Yang C, Zhou R, Duan Y, Zhang Y, Sun Y, Jiang L, Lian F, Tong X. Kang X, et al. Among authors: jin d. Drug Des Devel Ther. 2024 Dec 3;18:5573-5582. doi: 10.2147/DDDT.S487315. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39650851 Free PMC article. Clinical Trial.
Corrigendum to "Identification and validation of diagnostic markers related to immunogenic cell death and infiltration of immune cells in diabetic nephropathy" [Int. Immunopharmacol. 143(Pt 1) (2024) 113236].
Jin D, Tu X, Xu W, Zheng H, Zeng J, Bi P, Yang R, Li Y, Ni J, Zhu C, Chen H, Yu D, Wan F. Jin D, et al. Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113554. doi: 10.1016/j.intimp.2024.113554. Epub 2024 Nov 12. Int Immunopharmacol. 2024. PMID: 39537541 No abstract available.
74 results